Third Generation Lentiviral Vectors
This document outlines the UW Institutional Biosafety Committee's working definition of 3rd generation lentiviral vectors.
Vaccinia Virus Research Safety Policy
The Vaccinia Virus Research Safety Policy outlines the safety and occupational health requirements for work with vaccinia virus.
Current IBC meeting agenda
The agenda for the next Institutional Biosafety Committee (IBC) meeting is posted here at least 24 hours prior to the meeting.
Institutional Biosafety Committee (IBC) Charter
The charter for the Institutional Biosafety Committee (IBC) describes the purpose, function and operation of the University's IBC.
December 2014 IBC Meeting Minutes
November 2014 IBC Meeting Minutes
October 2014 IBC Meeting Minutes
September 2014 IBC Meeting Minutes
Institutional Biosafety Committee (IBC)
The Institutional Biosafety Committee (IBC) reviews, approves and oversees research involving the use of recombinant or synthetic DNA/RNA and other biohazards.
All work involving biohazards, including recombinant or synthetic DNA/RNA, is reviewed by the Institutional Biosafety Committee (IBC) and EH&S. The National Institutes of Health (NIH) require us to have an IBC. The committee approves procedures for procurement, use, storage, transportation and disposal of biohazardous material.